Investors gained access to a new international play on the Canadian Securities Exchange (CSE) as Israel-based medical marijuana producer and researcher IM Cannabis (IMC) (CSE:IMCC) officially launched on the exchange.

IMC started trading on Tuesday (November 5) under the ticker symbol “IMCC.” Shares of IMC opened at C$0.75 that day; as of 11:54 a.m. EST, the company was up 0.67 percent.


The company raised approximately C$20.4 million through a private placement in connection with its public launch. According to CEO Oren Shuster, IMC does not need to raise any more capital.

He added that despite the current landscape for marijuana investments on Canadian exchanges, he thinks his company is arriving at a proper time given its long-term roadmap.

“If you talk about timing, if you’re looking for the short term — and if we were only a financial player — it’s the worst time to go public,” Shuster told the Investing News Network (INN). “Because we don’t have to raise more money, and we are not looking at the short term, I think that for us it doesn’t matter what is happening in the short term.”

Despite being based in Israel, IMC is pursuing a European play for its marijuana operations — including its current shipment of medical cannabis to Germany through its pharmaceutical distribution company Adjupharm, which IMC acquired in March.

The company is betting on the development of the European market as a powerhouse in the medical cannabis space, a concept that has been shared by fellow players with interests in the continent, despite snags such as exporting problems.

Shuster touted the different options his company offers to investors looking within the marijuana space, with its presence in Israel and Europe, compared to the Canadian market. Shuster commented that he doesn’t see his company adding operations in Canada anytime soon.

He said investors are tired of promises from cannabis companies and are looking for existing results.

“The sentiment is now very negative now in the market because people understand that the market in Canada, it’s starting to be very competitive and there’s a strong push in the prices, and the projections that many companies gave are not close to reality,” he told INN.

The executive added that the company plans to expand its assets in Europe to include operations in Portugal and Greece.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

Ensuring estoraTMpatients have seamless access to their high-quality medical cannabis products

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announce that its subsidiary Pineapple Express Delivery Inc. (“Pineapple Express Delivery” or “PED”), a leading logistics technology company offering compliant and secure delivery of controlled substances and regulated products, has partnered with CannTrust Inc. to bring same-day and next-day delivery to estoraTM medical cannabis patients in Ontario

Keep reading... Show less

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less